Stock image for illustration purposes only - book cover, edition or condition may vary.
Non-Myeloablative Allogeneic Transplantation
. Ed(S): Bashey, Asad; Ball, Edward D.
€ 122.20
FREE Delivery in Ireland
Description for Non-Myeloablative Allogeneic Transplantation
Hardback. Non-myeloablative allogeneic stem cell transplantation is a major advance in the field of hematopoietic transplantation. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. Editor(s): Bashey, Asad; Ball, Edward D. Series: Cancer Treatment and Research. Num Pages: 216 pages, biography. BIC Classification: MJCL; MNK. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 14. Weight in Grams: 504.
Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach ... Read more
Non-myeloablative allogeneic stem cell transplantation (also known as mini-transplantation or reduced-intensity conditioning transplantation) is a major advance in the field of hematopoietic transplantation within the last 5 years. This approach uses non-cytotoxic or reduced-intensity cytotoxic therapy to prepare patients for allografting of hematopoietic stem cells and lymphocytes. It has the potential to deliver the potent anti-tumor immunotherapy and bone marrow replacement capacity of allogeneic stem cell transplantation to patients with reduced treatment-related morbidity and mortality. It may also enable allogeneic transplantation in patients who would be considered ineligible for conventional transplants because of co-morbidity or advanced age. However, this approach ... Read more
Product Details
Format
Hardback
Publication date
2002
Publisher
Kluwer Academic Publishers United States
Number of pages
216
Condition
New
Series
Cancer Treatment and Research
Number of Pages
216
Place of Publication
Dordrecht, Netherlands
ISBN
9780792376460
SKU
V9780792376460
Shipping Time
Usually ships in 15 to 20 working days
Ref
99-15
Reviews for Non-Myeloablative Allogeneic Transplantation